Lafayette Investments’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
– Sell
-9,281
Closed -$218K – 129
2023
Q1
$218K Sell
9,281
-375
-4% -$10.1K 0.06% 113
2022
Q4
$270K Hold
9,656
– – 0.08% 100
2022
Q3
$226K Hold
9,656
– – 0.07% 106
2022
Q2
$326K Hold
9,656
– – 0.09% 92
2022
Q1
$337K Sell
9,656
-37
-0.4% -$1.26K 0.08% 97
2021
Q4
$295K Buy
9,693
+1,500
+18% +$48.9K 0.07% 105
2021
Q3
$269K Buy
+8,193
New +$262K 0.07% 104

Other funds holding OGN

Lafayette Investments's OGN Position: Q2 2023 in Review

Lafayette Investments sold out of Organon & Co (OGN) in Q2 2023, closing a stake of 9,281 shares — an estimated $218K sold.

Lafayette Investments first reported a position in OGN in Q3 2021 and held it in 7 quarters. The position peaked at $337K in Q1 2022. 726 funds tracked by Wall St. Rank hold OGN as of Q2 2023.

  • Lafayette Investments reported no remaining Organon & Co position as of Q2 2023 after selling out during the quarter.
  • Lafayette Investments sold 9,281 Organon & Co shares in Q2 2023, an estimated $218K.
  • Lafayette Investments first reported a position in Organon & Co in Q3 2021 and held it in 7 quarters.
  • Lafayette Investments's Organon & Co position peaked at $337K in Q1 2022.
  • 726 funds tracked by Wall St. Rank held Organon & Co as of Q2 2023.

Based on Lafayette Investments's 13F filing for Q2 2023, filed 24 Jul 2023.